The UK government has committed £55.4 billion in detailed Department for Science, Innovation and Technology (DSIT) research and development allocations for the financial years 2026/27 to 2029/30, part of a wider £58.5 billion real-terms R&D budget for the period. UK Research and Innovation (UKRI) alone will deliver £38.6 billion of that total, rising to nearly £10 billion a year by 2029/30. For research administrators, the practical question is not the headline figure but what it does to grant pipelines, funder call volumes, and institutional planning cycles over the next four years.
UK research and development investment 2026 refers to the multi-year DSIT and UKRI budget settlement, published 30 October 2025, that sets funding envelopes for UK public research bodies from 2026/27 through 2029/30. This is a spending-review allocation, not a single-year grant round — and that distinction shapes how institutions should plan.
Contents
- What is changing in UK R&D investment for 2026?
- How is the £55.4bn allocation broken down by organisation?
- What does this mean for institutional grant pipelines?
- Will funder call volumes and success rates change?
- Answer-first questions research administrators are asking
- What should research offices do now?
- Outlook: the next four years
What is changing in UK R&D investment for 2026?
DSIT’s overall R&D budget will grow in real terms across the current Spending Review period, reaching £58.5 billion between 2026/27 and 2029/30, according to the department’s published R&D plans. Of that total, £55.4 billion has been allocated in detail across named organisations and programmes, with the remainder — covering programmes still being finalised — to be confirmed later.
This is a multi-year settlement rather than a single Budget announcement. It replaces annual uncertainty with a four-year envelope, which changes how institutions can realistically plan grant-writing capacity, co-investment commitments, and infrastructure bids.
How is the £55.4bn allocation broken down by organisation?
UKRI is the largest single recipient, with an expected £38.6 billion across the four years — its budget rising from £8.811 billion in 2025/26 to £9.986 billion in 2029/30. A more detailed breakdown of UKRI’s own council-level budgets followed in December 2025. The remaining allocation is split across UK contributions to EU programmes (including Horizon Europe and its successor), the UK Space Agency, the Met Office, the Advanced Research and Invention Agency (ARIA), the National Academies, the Office for Life Sciences, the National Measurement System, and the AI Security Institute (AISI).
| Organisation / programme | 2025/26 (£m) | 2029/30 (£m) | Total 2026/27–2029/30 (£m) |
|---|---|---|---|
| UK Research and Innovation (UKRI) | 8,811 | 9,986 | 38,586 |
| UK contribution to EU programmes | 2,736 | 2,200 | 8,716 |
| UK Space Agency | 668 | 720 | 2,798 |
| Met Office | 310 | 347 | 1,467 |
| ARIA | 184 | 400 | 1,220 |
| Office for Life Sciences | 129 | 146 | 925 |
| National Academies | 217 | 235 | 910 |
| National Measurement System | 130 | 145 | 558 |
| AI Security Institute (AISI) | 66 | 60 | 240 |
Source: DSIT, “Research and Development (R&D) plans to 2029/2030”, published 30 October 2025. Figures are planning allocations and, per DSIT’s own disclaimer, subject to in-year reallocation under its new “agile” budget-management approach.
What does this mean for institutional grant pipelines?
A rising, multi-year UKRI envelope — from £9.220 billion in 2026/27 to £9.986 billion by 2029/30 — gives research offices a firmer basis for forward-loading grant pipelines than the single-year settlements common in prior spending rounds. Institutions can use the published trajectory to model realistic co-investment and matched-funding exposure three to four years out, rather than reacting to annual uncertainty.
DSIT itself frames its new approach as more agile: funding can move across financial years where projects are delayed, be reallocated where a programme underspends, or be deprioritised where it is not delivering. That flexibility cuts both ways for pipeline planning — a confirmed four-year envelope is more predictable in total, but individual scheme budgets within it may shift year to year as DSIT and UKRI reprioritise.
- Build grant-pipeline forecasts around the confirmed multi-year UKRI trajectory, not single-year headline figures.
- Track the UK contribution to EU programmes carefully — it falls from £2.736 billion (2025/26) to £2.121 billion (2026/27) as Horizon Europe Guarantee costs wind down, which affects institutions relying on guarantee-funded EU collaborations.
- Monitor ARIA’s rapid growth (from £184 million to £400 million across the period) as a distinct, high-risk/high-reward funding route worth separate pipeline tracking from mainstream UKRI council schemes.
Will funder call volumes and success rates change?
UKRI’s own overall research and innovation budget is confirmed as rising during this Spending Review period, reaching almost £10 billion annually by 2030. A rising overall envelope does not automatically translate into proportionally more open calls — much depends on how UKRI’s nine councils allocate the increase between responsive-mode schemes, strategic priority programmes, and infrastructure.
DSIT has stated three explicit R&D priorities guiding allocation: protecting curiosity-driven, foundational science; supporting strategic government and societal priorities; and targeting innovative, UK-based company scale-up and growth. Research administrators should expect call volumes to grow unevenly across these three streams rather than uniformly across all disciplines.
Answer-first questions research administrators are asking
What is the UK government’s total R&D budget for 2026/27?
DSIT’s overall R&D budget totals £58.5 billion across 2026/27–2029/30, with £55.4 billion of that detailed by organisation in DSIT’s published plans as of 30 October 2025. UKRI is the largest single component, at £38.6 billion over the same four years.
How much has UKRI’s budget increased?
UKRI’s budget rises from £8.811 billion in 2025/26 to £9.220 billion in 2026/27, reaching £9.986 billion by 2029/30 — an increase of roughly £1.18 billion, or 13%, across the Spending Review period, per DSIT’s published allocation table.
Why is the UK’s EU programme contribution falling?
The UK’s contribution to EU programmes, including Horizon Europe, drops from £2.736 billion in 2025/26 to £2.121 billion in 2026/27 as Horizon Europe Guarantee costs wind down and the UK’s automatic correction mechanism under its association agreement takes effect, per DSIT.
What return does public R&D investment generate?
DSIT’s research states that each pound of public R&D investment leverages, on average, £2 of private R&D investment and generates £8 of net benefit in the long run, citing its “Value of Public R&D” research report (DSIT 2025/036).
What should research offices do now?
Institutional research offices, grants teams, and pro-vice-chancellors for research should treat this settlement as a four-year planning input rather than a one-off announcement.
- Re-baseline internal grant-pipeline forecasts against the confirmed year-by-year UKRI figures rather than the single £55.4 billion or £38.6 billion headline totals.
- Flag EU-programme-dependent projects for early review given the falling Horizon Europe Guarantee allocation.
- Build ARIA into distinct pipeline tracking, separate from mainstream UKRI responsive-mode schemes, given its faster proportional growth.
- Watch for UKRI’s own council-level budget detail and DSIT’s in-year reallocation decisions, since both bodies have flagged an “agile” approach that can shift funding between years and schemes.
Outlook: the next four years
The confirmed trajectory to nearly £10 billion in annual UKRI funding by 2029/30, inside a wider £58.5 billion DSIT envelope, gives UK research administration a rare degree of multi-year visibility. The practical work now shifts from interpreting the headline figure to modelling how each council, scheme, and international programme within it will move — a task best served by revisiting institutional grant-pipeline forecasts against DSIT’s published tables rather than summary press coverage. Sound research administration practice in this period means tracking these allocations at the same granularity DSIT itself now publishes them.